Cardiovascular Care
June 7, 2010
Electronic Prescribing Increases Generic and Formulary Drug Use
Electronic prescribing resulted in greater generic and formulary drug use, according to Crystal Chang, PharmD, and colleagues at Blue Shield of California, San Francisco. It also led to an average cost savings of 17.3% for both the member and the payer.
More »
April 16, 2010
Evidence-Based Perspective on Metabolic Syndrome and Use of Antipsychotics
Schizophrenia, a devastating mental illness that affects nearly 2.2 million Americans, is associated with high rates of morbidity and mortality.1 Persons with schizophrenia have a 20% shorter life expectancy than the general population.1,2 Furthermore, among persons with schizophrenia, there is an increased prevalence of metabolic syndrome characterized by a constellation of risk factors, including insulin resistance, abdominal obesity, dyslipidemia, hyperglycemia, and hypertension,3 More »
April 15, 2010
Reducing Cost-Related Medication Nonadherence in Patients With Diabetes
In the United States, it has been estimated that 7.8% of the total population has diabetes. In 2007, the direct medical expenditures for diabetes were about $116 billion and the total direct and indirect costs were $174 billion, according to the CDC.1 More »
March 26, 2010
Hyperparathyroidism Resulting From Lithium Treatment Remains Underrecognized
Until recently, I never paid much attention to the possibility that abnormalities of the parathyroid glands could be relevant to patients in my practice. But I decided to learn more about this issue when one of my patients with bipolar disorder who had been treated with lithium told me that she had been given a diagnosis of a parathyroid adenoma after her primary care physician noted hypercalcemia on routine testing. More »
March 26, 2010
Workers Fear Stigma of Mental Health Treatment
A national survey done by the American Psychiatric Association (APA) showed that workers are hesitant to seek treatment for mental health issues. Reasons cited included concerns about confidentiality or fears of loss of status in the workplace. More »
Showing 1 - 5 of 46 results.
Page of 10
First Previous Last
Selected Articles

Predicting the Risk of Type 2 Diabetes: When Does the Clock Start Ticking?

American medicine is undergoing the greatest financial scrutiny in its history. The hue and cry for reform stems primarily from the soaring costs of health care. However, placing the blame for these costs solely on increased utilization of technology, cutting-edge pharmaceuticals, cost-shifting hospitals, and physicians misses a bigger mark.

 

Diabetes and Cardiovascular Disease: Does Lowering Hemoglobin A1c Help or Harm?

Conflicting data about the safety and effectiveness of intensive glycemic control have caused confusion over the best approach to cardiovascular risk reduction in patients with diabetes. A recent meta-analysis has helped reconcile these seemingly contradictory data. The optimal mechanism, speed, and extent of glycated hemoglobin reduction are different for differing populations. For patients with recently diagnosed diabetes, aggressive treatment will lower cardiovascular risk. In patients who have diabetes of more than 15 years’ duration and are older and have other comorbidities, less aggressive treatment is indicated. For all patients, treatment of the dyslipidemia and hypertension that are associated with diabetes further reduces cardiovascular risk.

 

Coronary calcium scoring can be trusted to guide cardiac test selection

Coronary artery calcium scanning predicts the risk of myocardial infarction and sudden death accurately enough to guide the selection of diagnostic tests for symptomatic patients, according to a multicenter prospective study. 

 

Falling Through the Cracks: Middle-Aged Stroke Survivors Not Receiving Care

Recurrent stroke is an important health concern not only from a patient perspective but also from clinical and public health standpoints. Many studies have shown that the risk of a second cerebral infarction is greatest immediately following the primary event. Consequently, clinical management of stroke survivors is focused on preventive therapy to minimize risk.Recurrent stroke is an important health concern not only from a patient perspective but also from clinical and public health standpoints. Many studies have shown that the risk of a second cerebral infarction is greatest immediately following the primary event. Consequently, clinical management of stroke survivors is focused on preventive therapy to minimize risk. 
Mashup Tool
Realizing and Allocating Savings From Improving Health Care Quality and Efficiency
www.cdc.gov - 9/19/11
accrue to patients employers providers or payers.” A social case would ...
Secondary Prevention of Myocardial Infarction With Nonpharmacologic Strategies in a Medicaid Cohort
www.cdc.gov - 9/18/11
method that other payers including the Department of Social and Health ... Adherence to cardiovascular disease prevention guidelines improves survival reduces recurrent events and the ...
The costs of atrial fibrillation in patients with cardiovascular comorbidities—a longitudinal analysis of German health insura
europace.oxfordjournals.org - 8/31/11
fibrillation in patients with cardiovascular comorbidities—a longitudinal ... a German statutory health insurance company covering ?5 ... weekly costs and from the third-party payer's perspective ...
ACCF/AHA 2011 Key Data Elements and Definitions of a Base Cardiovascular Vocabulary for Electronic Health Records: A Report of t
content.onlinejacc.org - 7/4/11
payers regulators and consumers may draw conclusions about care and outcomes. ... representation from adult and pediatric cardiovascular medicine and surgery. ...
Position Statement Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of
care.diabetesjournals.org - 5/31/11
policy makers and payers for healthcare as well as by researchers and manufacturers. ...

Result Pages: 1 2 3 4 5 6 Previous Next